Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Income from Continuing Operations (2023 - 2025)

Guardian Pharmacy Services' Income from Continuing Operations history spans 3 years, with the latest figure at 21265000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 79.59% year-over-year to 21265000.0; the TTM value through Dec 2025 reached 48958000.0, up 168.92%, while the annual FY2025 figure was 48958000.0, 168.92% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 21265000.0 at Guardian Pharmacy Services, up from 9593000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 21265000.0 in Q4 2025 and bottomed at 105817000.0 in Q3 2024.
  • The 3-year median for Income from Continuing Operations is 9593000.0 (2025), against an average of 835111.11.
  • The largest YoY upside for Income from Continuing Operations was 109.07% in 2025 against a maximum downside of 44.3% in 2025.
  • A 3-year view of Income from Continuing Operations shows it stood at 14559000.0 in 2023, then fell by 18.67% to 11841000.0 in 2024, then surged by 79.59% to 21265000.0 in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Income from Continuing Operations are 21265000.0 (Q4 2025), 9593000.0 (Q3 2025), and 8827000.0 (Q2 2025).